Cart
sales@molnova.com
V2 receptor (V2R) agonist
CAS No. 1647120-04-4
V2 receptor (V2R) agonist( c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate )
Catalog No. M29904 CAS No. 1647120-04-4
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameV2 receptor (V2R) agonist
-
NoteResearch use only, not for human use.
-
Brief Descriptionc(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.
-
Descriptionc(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.
-
In Vitro——
-
In Vivo——
-
Synonymsc(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1647120-04-4
-
Formula Weight1006.63
-
Molecular FormulaC44H64ClN11O10S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Wi?niewski K, et al. Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. J Med Chem. 2019 May 23;62(10):4991-5005.
molnova catalog
related products
-
Arvenin III
Arvenin III is a useful organic compound for research related to life sciences.
-
Kynurenic acid
Kynurenic acid, a natural metabolite of tryptophan via the kynurenine pathway, is a broad-spectrum excitatory amino acid antagonist.
-
Methyl Nonadecanoate
Methyl Nonadecanoate is a fatty acid methyl ester.
